ILSUNG IS CO., LTD. Logo

ILSUNG IS CO., LTD.

Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.

003120 | KO

Overview

Corporate Details

ISIN(s):
KR7003120003
LEI:
Country:
South Korea
Address:
서울특별시 용산구 원효로84길 9, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Based on available data, ILSUNG IS CO., LTD. is a pharmaceutical company. The firm's core focus is on antibiotics, cardiovascular drugs, anesthetics, and contrast media. It is actively expanding its therapeutic areas to include gastrointestinal (GI), central nervous system (CNS), and other related fields. The company's activities involve managing drug pipelines, conducting clinical trials, and developing patented technologies in the nervous system disease domain. Note: No information was found to support the premise of the company being a financial data provider; all relevant search results indicate a pharmaceutical business.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.2 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 922.9 KB
2025-07-22 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 44.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 833.6 KB
2025-04-28 00:00
Board/Management Information
대표이사(대표집행임원)변경(안내공시)
Korean 6.4 KB
2025-04-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.2 MB
2025-03-21 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 29.3 KB
2025-03-21 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 11.3 KB
2025-03-13 00:00
Annual Report
[첨부추가]사업보고서 (2024.12)
Korean 1.2 MB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 81.8 KB
2025-02-20 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.3 KB
2025-02-20 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 16.2 KB
2025-02-20 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 9.4 KB
2025-02-05 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 11.5 KB

Automate Your Workflow. Get a real-time feed of all ILSUNG IS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ILSUNG IS CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ILSUNG IS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea
196170
ALTERITY THERAPEUTICS LTD Logo
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
Alto Neuroscience, Inc. Logo
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
ALUMIS INC. Logo
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN
Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden
ALZ
AMARIN CORP PLC\UK Logo
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
United States of America
AMRN
AMGEN INC Logo
Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.
United States of America
AMGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.